Results 31 to 40 of about 187,331 (234)

Non-HDL-C, Symptomatic Intracranial Arterial Stenosis, and Recurrent Vascular Risk in Minor Stroke. [PDF]

J Atheroscler Thromb
We aimed to assess the association between non-high-density lipoprotein cholesterol (non-HDL-C) and symptomatic intracranial artery stenosis (sICAS), as well as the impact of non-HDL-C on recurrent vascular events in patients with mild ischemic stroke ( NIHSS score ≤ 5).This prospective study was based on data from patients presenting within 72 hours ...
Fan H, Liu T, Zhang K, Wang Y, Wang R, Yang F, Chen F, Zhang Y, Guo H, Li X, Wu X, Niu X.   +11 more
europepmc   +3 more sources

Association between non-high-density lipoprotein to high-density lipoprotein ratio and reversion to normoglycemia in people with impaired fasting glucose: a 5-year retrospective cohort study

Diabetology & Metabolic Syndrome, 2023
Objective The relationship between the non-high-density lipoprotein to high-density lipoprotein ratio (non-HDL-c/HDL-c ratio) and changes in glycemic status as well as the development of type 2 diabetes mellitus (T2DM) has been well established. However,
Zihe Mo, Yong Han, Changchun Cao, Qingli Huang, Yanhua Hu, Zhiqun Yu, Haofei Hu   +6 more
doaj   +1 more source

LDL-C, NON-HDL-C and APO-B for cardiovascular risk assessment: Looking for the ideal marker. [PDF]

Indian Heart J, 2021
The traditional approach to the management of coronary artery disease (CAD) focuses mainly on low density lipoprotein cholesterol (LDL-C) which is often considered a crucial risk factor for the progression of atherosclerosis. Despite its extensive use in predicting CAD risk, it has become a sub-optimal marker owing to several limitations. Recently, non-
Aggarwal DJ, Kathariya MG, Verma DPK.
europepmc   +4 more sources

Utility of non-HDL-C in predicting proteinuria remission of idiopathic membranous nephropathy: a retrospective cohort study. [PDF]

Lipids Health Dis, 2021
Abstract Background Idiopathic membranous nephropathy (IMN) may have various clinical outcomes. Hyperlipidemia is quite common in IMN. However, the utility of the lipid profile in predicting outcomes remains unknown. This study aimed to explore the correlation between hyperlipidemia and proteinuria remission in IMN.
Dong L, Wei W, Han M, Xu G.
europepmc   +5 more sources

Trends in dyslipidemia prevalence among Uyghur adults of different genders in China: a retrospective cohort study [PDF]

PeerJ
Background To analyze the prevalence and epidemiological characteristics of dyslipidemia among adults of different genders in Xinjiang, China, providing a basis for promoting ideal lipid management among the Uyghur population.
Gulinigaer Maimaitituersun, Subinuer Jureti, Ziyu Yi, Yaqi Zhou, Meng Li, Mengwei Wei, Ziyang Liu, Menglong Jin, Zhenyan Fu   +8 more
doaj   +2 more sources

Effect of alirocumab on individuals with type 2 diabetes, high triglycerides, and low high-density lipoprotein cholesterol

Cardiovascular Diabetology, 2020
Background Mixed dyslipidemia [elevated non-high-density lipoprotein cholesterol (non-HDL-C) and triglycerides (TGs), and decreased HDL-C] is common in type 2 diabetes mellitus (T2DM) and is associated with increased cardiovascular risk.
Helen M. Colhoun, Lawrence A. Leiter, Dirk Müller-Wieland, Bertrand Cariou, Kausik K. Ray, Francisco J. Tinahones, Catherine Domenger, Alexia Letierce, Marc Israel, Rita Samuel, Stefano Del Prato   +10 more
doaj   +1 more source

Evaluation of lipid parameters and bioindices in patients with different stages of chronic renal failure [PDF]

Vojnosanitetski Pregled, 2012
Background/Aim. Cardiovascular morbidity and mortality are markedly increased in chronic renal failure (CRF). The aim of this study was to evaluate lipid parameters and bioindices in patients with different stages of CRF. Methods.
Čabarkapa Velibor, Đerić Mirjana, Stošić Zoran, Sakač Vladimir, Lozanov-Crvenković Zagorka, Vučković Biljana   +5 more
doaj   +1 more source

Standardization of Apolipoprotein B, LDL‐Cholesterol, and Non‐HDL‐Cholesterol

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Concern continues about whether the measurement of apolipoprotein B (apoB) is adequately standardized, and therefore, whether apoB should be applied widely in clinical care. This concern is misplaced.
John H. Contois, Michel R. Langlois, Christa Cobbaert, Allan D. Sniderman   +3 more
doaj   +1 more source

Association of the TG/HDL-C and Non-HDL-C/HDL-C Ratios with Chronic Kidney Disease in an Adult Chinese Population

Kidney & Blood Pressure Research, 2017
Background/Aims: Evidence indicates a role for dyslipidemia in the development of chronic kidney disease (CKD). However, the association of lipid abnormalities and their ratios with kidney disease using the new CKD Epidemiology Collaboration (CKD-EPI ...
Jia Wen, Yiyin Chen, Yun Huang, Yao Lu, Xing Liu, Honghao Zhou, Hong Yuan   +6 more
doaj   +1 more source

Higher non-HDL-cholesterol to HDL-cholesterol ratio linked with increased nonalcoholic steatohepatitis

Lipids in Health and Disease, 2018
Background Non-HDL-cholesterol to HDL-cholesterol (non-HDL-c/HDL-c) ratio is a feasible predictor for coronary heart disease, metabolic syndrome, and insulin resistance.
Dianhui Wang, Ling Wang, Zhanqing Wang, Shihong Chen, Yihong Ni, Dongqing Jiang   +5 more
doaj   +1 more source